For Clinicians
Early recognition, longitudinal tracking, and emerging evidence: organized for busy clinicians who care for patients with sclerosing skin disease.
Quick Reference
Early identification of disease subtype and activity can meaningfully affect long-term outcomes and patient experience. Skin induration pattern, distribution, and associated features guide classification.
Standardized monitoring tools (mLoSSI, LoSDI for morphea; mRSS for systemic sclerosis) support objective disease activity assessment across visits.
What we still don't know — and what's coming — framed for practice. References and links to current literature will be updated regularly.
Sclerosing skin diseases often benefit from rheumatology, physical therapy, and mental health co-management. Knowing when and who to refer is part of comprehensive care.
References & Links
Curated references will be added here. Check back as this section grows. Suggest a resource via the contact information on the Disclosures page.
Coming Soon
This section will include: classification criteria references, validated outcome measure tools, key society guidelines (AAD, ACR, EULAR), and links to patient education handouts you can share directly.